New Guidance on Resmetirom and Semaglutide for MASH

(MedPage Today) — At the American Association for the Study of Liver Diseases (AASLD) annual meeting, a session highlighted new guidance on using resmetirom (Rezdiffra) and semaglutide (Ozempic, Wegovy) for metabolic dysfunction-associated steatohepatitis…